Efficacy and safety of adalimumab in treatment of moderate to severe hidradenitis suppurativa: Results from the placebo-controlled portion of a phase II, randomized, double-blind study
2011 ◽
Vol 64
(2)
◽
pp. AB155
Keyword(s):
Phase Ii
◽